Technology that restores natural physiologic outflow as a foundation of significant/steady/sustained glaucoma management.
There’s no risk. Start your trial today to see profiles of Glaukos (NASDAQ: GKOS) plus 5517 other startups.
Start Free 7 Day Trial Now